1-5 of 5
Kim Dong-Wook
Close
Sort by
Journal Articles

Imatinib Suspension and Validation (ISAV) Study: Results at 24 Months

Silvia Mori, PhD, Philipp le Coutre, MD, Elisabetta Abruzzese, MD, Bruno Martino, MD, Ester Pungolino, MD, Chiara Elena, MD, Ivana Pierri, MD, Sarit E. Assouline, MDMSc, Anna D'Emilio, MD, Antonella Gozzini, MD, Pilar Giraldo, MD PhD, Fabio Stagno, MD PhD, Alessandra Iurlo, MD PhD, Andrea Aroldi, MD, Michela Luciani, RN, Giulia De Riso, RN, Kim Dong-Wook, MD PhD, Alessandra Pirola, MSc, Anna Petroccione, Maria Luisa Bonanomi, Patrizia Crivori, PhD, Rocco Piazza, MDPhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2015) 126 (23): 2775.
https://doi.org/10.1182/blood.V126.23.2775.2775
Published: 2015
Journal Articles

ABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Exhibits Safety and Promising Single- Agent Activity in a Phase I Study of Patients with CML with Failure of Prior TKI Therapy

Oliver G. Ottmann, MD, Giuliana Alimena, Daniel J. DeAngelo, MD PhD, Yeow-Tee Goh, MBBS, MMed, Michael C. Heinrich, MD, Andreas Hochhaus, MD, Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Francois-Xavier Mahon, MD PhD Professor, Michael J. Mauro, MD, Hironobu Minami, MD D.MDSci., Marie Huong Nguyen, MD, Delphine Rea, Juan Luis Steegmann, MD, Arkendu Chatterjee, Varsha Iyer, Noelia Martinez, Gary J. Vanasse, MD, Kim Dong-Wook, MD PhD
Journal: Blood
Blood (2015) 126 (23): 138.
https://doi.org/10.1182/blood.V126.23.138.138
Published: 2015
Journal Articles

The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis

Silvia Mori, PhD, Elisabetta Vagge, MD, Philipp le Coutre, MD, Elisabetta Abruzzese, MD, Bruno Martino, MD, Ester Pungolino, MD, Chiara Elena, MD, Ivana Pierri, MD, Sarit Assouline, MD MSc, Anna D'Emilio, MD, Antonella Gozzini, MD, Pilar Giraldo, MD PhD, Fabio Stagno, MD PhD, Alessandra Iurlo, MD PhD, Michela Luciani, RN, Giulia De Riso, RN, Kim Dong-Wook, MD PhD, Alessandra Pirola, M.Sc., Anna Petroccione, Agnese Lodolo D'Oria, Patrizia Crivori, PhD, Rocco Piazza, MD PhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2014) 124 (21): 813.
https://doi.org/10.1182/blood.V124.21.813.813
Published: 2014
Journal Articles

Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia

Vera Magistroni, PhD, Nitesh Sharma, Rocco Piazza, MD, PhD, Jason G Harb, Ph.D, Roberta Spinelli, M.Sc., Alessandra Pirola, M.Sc., Justin Ellis, Kim Dong-Wook, Danilo Perrotti, MD, Ph.D, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2012) 120 (21): 3727.
https://doi.org/10.1182/blood.V120.21.3727.3727
Published: 2012
Journal Articles

Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia Abrogate an Ubiquitination Site and Dysregulate SETBP1 Protein Levels

Carlo Gambacorti-Passerini, MD, Simona Valletta, Nils Winkelmann, MD, Sara Redaelli, PhD, Roberta Spinelli, M.Sc., Alessandra Pirola, M.Sc., Laura Antolini, Luca Mologni, PhD, Carla Donadoni, Elli Papaemmanuil, PhD, Susanne Schnittger, PhD, Kim Dong-Wook, Jacqueline Boultwood, MD, Fabio Rossi, Giuseppe Gaipa, PhD, Greta De Martini, MD, Paola Francia di Celle, PhD, Hyun G. Jang, Valeria Fantin, PhD, Graham R Bignell, Vera Magistroni, PhD, Torsten Haferlach, MD, Enrico Maria Pogliani, MD, Peter Campbell, MD Phd, Andrew J Chase, PhD, William J Tapper, PhD, Nicholas C.P. Cross, PhD, FRCPath, Rocco Piazza, MD, PhD
Journal: Blood
Blood (2012) 120 (21): LBA-2.
https://doi.org/10.1182/blood.V120.21.LBA-2.LBA-2
Published: 2012